103 related articles for article (PubMed ID: 24163967)
1. Cytotoxicity of triphenyltin(IV) methyl- and ethylisopropyldithiocarbamate compounds in chronic myelogenus leukemia cell line (K-562).
Awang N; Kamaludin NF; Hamid A; Mokhtar NW; Rajab NF
Pak J Biol Sci; 2012 Sep; 15(17):833-8. PubMed ID: 24163967
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line.
Koc A; Ozkan T; Hekmatshoar Y; Gurkan-Alp AS; Aktan F; Buyukbingol Z; Sunguroglu A; Buyukbingol E; Karabay AZ
Anticancer Agents Med Chem; 2018 Feb; 17(14):1924-1930. PubMed ID: 28403785
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect of organotin(IV) benzylisopropyldithiocarbamate compounds on Chang liver cell and hepatocarcinoma HepG2 cell.
Awang N; Kamaludin NF; Ghazali AR
Pak J Biol Sci; 2011 Aug; 14(15):768-74. PubMed ID: 22303582
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and crystal structure of organotin(IV) N-butyl-N-phenyldithiocarbamate compounds and their cytotoxicity in human leukemia cell lines.
Kamaludin NF; Awang N; Baba I; Hamid A; Meng CK
Pak J Biol Sci; 2013 Jan; 16(1):12-21. PubMed ID: 24199481
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
[TBL] [Abstract][Full Text] [Related]
6. Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231.
Hunakova L; Brtko J
Toxicol Lett; 2017 Sep; 279():16-21. PubMed ID: 28709983
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid.
Pantelić NĐ; Zmejkovski BB; Božić B; Dojčinović B; Banjac NR; Wessjohann LA; Kaluđerović GN
J Inorg Biochem; 2020 Oct; 211():111207. PubMed ID: 32801055
[TBL] [Abstract][Full Text] [Related]
8. Cellular and DNA Toxicity Study of Triphenyltin Ethyl Phenyl Dithiocarbamate and Triphenyltin Butyl Phenyl Dithiocarbamate on K562, Leukemia Cell Line.
Hamid A; Rajab NF; Charmagne Y; Awang N; Jufri NF; Rasli NR
Anticancer Agents Med Chem; 2024; 24(1):58-65. PubMed ID: 37921147
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
Li L; Keating MJ; Plunkett W; Yang LY
Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
[TBL] [Abstract][Full Text] [Related]
10. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
11. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
12. Spiroquinazolinone-induced cytotoxicity and apoptosis in K562 human leukemia cells: alteration in expression levels of Bcl-2 and Bax.
Ghasemian M; Mahdavi M; Zare P; Ali Hosseinpour Feizi M
J Toxicol Sci; 2015 Feb; 40(1):115-26. PubMed ID: 25743751
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
[TBL] [Abstract][Full Text] [Related]
14. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
15. Series of Organotin(IV) Compounds with Different Dithiocarbamate Ligands Induced Cytotoxicity, Apoptosis and Cell Cycle Arrest on Jurkat E6.1, T Acute Lymphoblastic Leukemia Cells.
Rasli NR; Hamid A; Awang N; Kamaludin NF
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110610
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line.
Guo-Bao W; Xiao-Qin C; Qi-Rong G; Jie L; Gui-Nan L; Yue L
Leuk Lymphoma; 2010 Jun; 51(6):1090-7. PubMed ID: 20470221
[TBL] [Abstract][Full Text] [Related]
17. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ
Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456
[TBL] [Abstract][Full Text] [Related]
18. Sulfonated Schiff base Sn(IV) complexes as potential anticancer agents.
Hazra S; Paul A; Sharma G; Koch B; da Silva MFCG; Pombeiro AJL
J Inorg Biochem; 2016 Sep; 162():83-95. PubMed ID: 27338202
[TBL] [Abstract][Full Text] [Related]
19. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
